The Importance of Molecular Profiling in Delivering Guideline-Recommended Care—From Genetic Sequencing to Patient Outcomes - Top-Institutions - MDSpire

The Importance of Molecular Profiling in Delivering Guideline-Recommended Care—From Genetic Sequencing to Patient Outcomes

  • By

  • Igor Makhlin

  • April 7, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Molecular Oncology
    • Genomic Medicine
    • Translational Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cancer Genomics
    • Precision Oncology
    • Clinical Trials

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Molecular Diagnostics
    • Oncologic Genomics
    • Health Disparities Research

  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Cancer Genomics
    • Molecular Pathology
    • Translational Oncology

  • #5

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Precision Oncology
    • Molecular Diagnostics
    • Cancer Genomics

Original Source(s)

The Importance of Molecular Profiling in Delivering Guideline-Recommended Care—From Genetic Sequencing to Patient Outcomes

  • by Igor Makhlin

  • April 7, 2026

Related Content

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review

Biotech exec Jeremy Levin on the industry’s strategic turning point